Jessie F. Medeiros

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Journal: Leukemia

Published: September 08, 2025

A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in Myelofibrosis.

A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in Myelofibrosis.

Journal: Blood

Published: June 24, 2025

A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

Journal: Blood

Published: June 24, 2025

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Journal: Leukemia

Published: January 28, 2025

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Journal: Blood advances

Published: November 13, 2023

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

Journal: American journal of hematology

Published: June 01, 2022

Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.

Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 10, 2022

Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock.

Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock.

Journal: European journal of heart failure

Published: April 23, 2022

SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data.

SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data.

Journal: Bioinformatics (Oxford, England)

Published: October 12, 2021

Mapping the cellular origin and early evolution of leukemia in Down syndrome.

Mapping the cellular origin and early evolution of leukemia in Down syndrome.

Journal: Science (New York, N.Y.)

Published: November 07, 2020

Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.

Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.

Journal: Nature communications

Published: June 23, 2020

Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms.

Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms.

Journal: Blood

Published: September 26, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026